XTSX
WBE
Market cap5mUSD
Jul 08, Last price
0.22CAD
1D
0.00%
1Q
4.76%
Name
Westbond Enterprises Corp
Chart & Performance
P/E
—
P/S
0.81
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.72%
Rev. gr., 5y
-3.17%
Revenues
10m
+4.91%
Net income
-52k
L-75.14%
CFO
1m
+136.28%
Dividend
Dec 02, 20220.005 CAD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
WestBond Enterprises Corporation, along with its subsidiary WestBond Industries Inc., specializes in the manufacturing and distribution of disposable paper products. These items are designed for a variety of applications within the medical, hygienic, and industrial sectors across Canada and the United States. The company's extensive product catalog includes personal care paper goods, such as various rolled and folded hand towels, jumbo roll, conventional, and coreless bathroom tissues, and both standard and air-laid center-feed towels. For the hospitality and food service industries, WestBond provides air-laid napkins, guest towels, air-laid kitchen roll towels, and single-use bar towels. Its clinical offerings feature a comprehensive range of products, including sheets, examination table coverings, waterproof sheets, pillowcases, examination drapes and gowns, and specialized ultrasound towels and wipes. Additionally, the company supplies products tailored for long-term care facilities, such as folded and rolled air-laid patient wipes and waterproof underpads. WestBond also produces disinfectant wipes and sprays, and offers bulk airlaid rolls to other converting businesses. The company primarily sells its products through medical and industrial distributors, though it also engages in direct sales to end-users. WestBond Enterprises Corporation maintains its corporate headquarters in Delta, Canada.
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||